UPC earnings: real EPS beat/miss history, P/E -0.00. Updated 2026-07-23.
Universe Pharmaceuticals (UPC) Research Hub
Universe Pharmaceuticals (UPC) trades on NASDAQ, CN in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-09-11, shares last closed at 4.36 USD (+4.56%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.00, market cap 0.00B. This hub links to the full technical, earnings and options research available for UPC.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - Specialty & Generic) |
|---|---|
| Exchange | NASDAQ, CN |
| Last close | 4.36 USD (+4.56%) |
| 52-week range | 2.6 USD – 8 USD |
| Trend regime | Range |
| 14-day RSI | 32.2 (Bearish) |
| Trailing P/E | -0.00 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
Available research for UPC
Covered Call on UPC: how it works, illustrative setup around the real 4.36 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on UPC: how it works, illustrative setup around the real 4.36 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on UPC: how it works, illustrative setup around the real 4.36 USD price, max profit/loss, breakeven and when to use it. Educational.
UPC technical analysis: range, last 4.36 USD, RSI 32.2, 52w range 2.6 USD–8 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is UPC in?
Universe Pharmaceuticals (UPC) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NASDAQ, CN.
Is UPC in an uptrend or downtrend?
As of 2026-09-11, UPC is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is UPC's trailing P/E ratio?
UPC's trailing P/E is -0.00, with a market cap of 0.00B. See the earnings research page for full valuation detail.